Molecular TB testing, closer to the patient.
N2M Company Limited brings the Pluslife MiniDock MTB Test to Uganda — a compact, near point-of-care nucleic acid test that delivers PCR-level TB results in under 30 minutes from sputum or a simple tongue swab.
A new era for decentralised TB diagnosis
N2M Company Limited is the authorized distributor and implementation partner for Pluslife products in Uganda. Through this collaboration, N2M is responsible for the supply, distribution, installation, technical support, user training, and after-sales service of Pluslife diagnostic solutions across the country. The partnership aims to improve access to innovative molecular diagnostic technologies by ensuring that healthcare facilities receive high-quality products, timely technical assistance, and continuous operational support. N2M works closely with Pluslife to facilitate product deployment, capacity building of healthcare workers, and ongoing monitoring to ensure effective utilization of the technology. Together, N2M and Pluslife are committed to strengthening diagnostic capacity in Uganda by providing reliable, user-friendly, and innovative testing solutions that support improved patient care and public health outcomes.
The MiniDock MTB Test combines the palm-sized MiniDock Ultra analyser, the Pluslife Thermolyse pre-treatment unit and single-use MTB Nucleic Acid Test Cards. Together they let health centres test, diagnose and link patients to care in a single visit, without sending samples to a central laboratory.
Designed to improve access for children, older adults, primary-care patients and people living with HIV — groups for whom producing sputum is often difficult.
- Same-day testing and linkage to treatment
- Tongue swab option when sputum cannot be obtained
- Runs on mains power, power bank or UPS — suited to lower-level facilities
- Supplied, installed and supported locally by N2M
Built for the realities of TB care
Supports faster triage and patient management by reducing time to action, increasing detection and lowering cost.
Fast
Results in 5–25 minutes, so patients can be diagnosed while still at the clinic.
Accurate
PCR-level performance using isothermal nucleic acid amplification.
Affordable
Low per-test cost — reported 36–59% lower testing cost than Xpert Ultra.*
Simple
About 1–2 minutes of hands-on time. Minimal training needed for lab staff.
One-Visit Care
Same-day testing and care linkage reduces loss to follow-up.
Flexible
Cold-chain free test cards; works with a power bank or UPS during outages.
From sample to result in four steps
Sample Collection
Sputum, or a 30-second tongue swab when sputum is unavailable.
Mix Sample
Mix the sample in the buffer tube (about 10 inversions).
1-Step Pretreatment
Heat and vortex in the Pluslife Thermolyse — 3000 rpm, 75 °C, 5 min.
Run Test & Read Result
Load the test card into MiniDock. Results in 5–25 min on PC software or app.
Backed by WHO guidance and peer-reviewed research
WHO Evidence Review
Broad WHO-reviewed evidence supports the use of NPOC-NAATs for TB diagnosis.
WHO consolidated guidelines on tuberculosis, Module 3: Diagnosis — NPOC-NAATs.NEJM Publication
Independent multi-country study validates MiniDock MTB using sputum and tongue swab samples.
Yerlikaya S, et al. N Engl J Med. 2026;394:1710–1722.Sampling Convenience
Tongue swabs expand access when sputum is difficult to obtain.
Moe CA, et al. Clin Infect Dis. 2026; ciag077.Health Economics
Lower testing cost may support broader access and improved cost-effectiveness.
Moe CA, et al. medRxiv. 2025. doi:10.1101/2025.08.14.25333714.Technical specifications
MiniDock Ultra (Analyser)
| Dimensions | 101 × 91 × 65 mm |
| Weight | 240 g |
| Connectivity | USB Type-C / Wi-Fi |
| Storage temperature | −20 °C to 55 °C |
| Operating conditions | 5 °C to 50 °C; ≤90% RH, non-condensing |
MTB Nucleic Acid Test Card
| Target pathogen | MTBC DNA |
| Analytical LoD (M. tuberculosis H37Ra) | 5 CFU/mL (sputum); 1 CFU/swab (tongue swab) |
| Turnaround time | ≤ 30 min |
| Shelf life | 13 months at 0 °C to 40 °C |
| Sample type | Sputum / tongue swab |
| Pack size | 10 tests per kit |
National launch of the Near Point-of-Care TB Test
The Ministry of Health, together with the Uganda Supranational Reference Laboratory and the National TB & Leprosy Control Division (NTLP), officially launched the near point-of-care TB test under the theme “Expanding Access to TB Diagnosis, Care and Treatment.” N2M exhibited the MiniDock MTB system and demonstrated live testing to health officials, partners and clinicians.







Local supply, installation and support
Since 2014, N2M Company Limited has supplied medical and laboratory equipment to health institutions across Uganda. With the MiniDock MTB Test, we provide end-to-end support.
Supply & Logistics
Reliable stock of analysers, test cards and consumables, delivered nationwide.
Installation
On-site set-up of MiniDock and Thermolyse units at your facility.
Training
Hands-on training for laboratory and clinical staff.
After-Sales Support
Maintenance, troubleshooting and spare parts from our Kampala team.
Bring near point-of-care TB testing to your facility
Talk to us about pricing, demonstrations and placement of the MiniDock MTB Test.
